Sensible Diagnostics Gets $1M NIH RADx Award for COVID Test Development
Sensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MorePosted by Andy Lundin | Aug 21, 2023 | Covid 19 |
Sensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MorePosted by Andy Lundin | Aug 16, 2023 | Covid 19, Mass Spectrometry Reagents & Test Kits |
The new COVID detection method employs equipment already being used in hospitals and labs to detect bacterial and fungal infections.
Read MorePosted by Andy Lundin | Aug 15, 2023 | Covid 19 |
Recent studies have highlighted the power of dogs in detecting COVID, even when obscured by other viruses, such as common colds and the flu.
Read MorePosted by Andy Lundin | Aug 11, 2023 | Diagnostic Technologies |
A new study links a part of the complete blood count (CBC) with risk of hospital admission and in-hospital mortality.
Read MorePosted by Andy Lundin | Aug 4, 2023 | Molecular Diagnostics, Respiratory Disease |
The FDA granted 510(k) clearance to BD’s Respiratory Viral Panel for the BD MAX System, a diagnostic test that ID’s respiratory viruses.
Read More